Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.

Revenue
+9.98%
EPS
+29.4%
Free cash flow
+6.21%
Total debt
−2.20%

Quarter to September 2026, against a year earlier

253.32 1.42 −0.56%
Market cap
$28.0B
P/E
25.0×
Fwd P/E
24.4×
Dividend yield
1.33%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
19.56 19.39 18.55 19.33 10.90 11.24 16.79 15.45 17.57 20.23
Piotroski F-Score
8 4 5 4 8 9 7 5 7 5
P/S ratio
1.75 1.70 1.70 1.83 2.00 1.69 1.85 1.50 1.83 1.79
Altman Z-Score
3.15 2.79 3.09 3.65 4.06 3.50 3.06 3.16 3.51 3.53
Altman Z″-Score (non-manufacturers)
3.53 3.31 3.78 3.93 4.44 4.70 3.81 3.83 4.05 4.24
P/FCF ratio
14.17 18.42 18.25 13.75 11.82 10.06 16.97 13.86 14.68 15.73
Beneish M-Score
(2.65) (2.54) (2.56) (2.85) (2.58) (2.30) (2.61) (2.54) (2.63) (2.57)
P/Operating CF
41.42 36.09 29.93 54.10 44.96 29.52 41.12 38.39 41.95 36.87
Dividend Safety Score
85 — — — — — — — — —
P/B ratio
2.67 2.46 2.49 3.05 3.34 2.35 2.52 2.15 2.73 2.78
EV/Sales
2.22 2.27 2.14 2.20 2.30 1.99 2.32 2.00 2.32 2.26
EV/EBITDA
11.53 12.19 11.64 11.65 8.88 8.07 11.47 10.70 11.98 10.69
EV/FCF
18.04 24.66 22.92 16.54 13.53 11.86 21.22 18.46 18.63 19.83
Current Ratio
1.04 1.10 1.31 1.22 1.56 1.72 1.25 0.94 1.24 1.56
Net Debt/EBITDA
2.47 3.08 2.37 1.97 1.13 1.23 2.29 2.67 2.54 2.21
Debt/Equity
0.79 0.91 0.74 0.67 0.62 0.59 0.84 0.74 0.76 0.80
ROE
14.10% 13.17% 13.85% 15.18% 29.91% 22.81% 15.67% 14.40% 16.06% 13.70%
ROA
6.10% 5.74% 6.33% 7.12% 14.39% 10.61% 7.20% 6.84% 7.49% 6.40%
ROIC
7.81% 6.74% 7.61% 9.30% 15.46% 12.74% 8.30% 7.62% 8.46% 9.93%
Return on Tangible Assets
42.90% 37.07% 35.82% 44.58% 73.77% 48.99% 43.93% 61.69% 55.38% 40.66%
Average Days of Receivables
46.57 48.21 47.74 44.13 48.65 58.79 50.22 49.05 45.56 46.85
Earnings Yield
5.11% 5.16% 5.39% 5.17% 9.17% 8.89% 5.96% 6.47% 5.69% 4.94%
Free Cash Flow Yield
7.06% 5.43% 5.48% 7.27% 8.46% 9.94% 5.89% 7.21% 6.81% 6.36%
Free Cash Flow per Share
12.24 8.19 7.71 11.33 14.64 11.84 6.29 6.01 6.74 5.88
Book value per Share
64.92 61.38 56.63 51.12 51.86 50.81 42.44 38.73 36.17 33.29
Free Cash Flow
1,359.00 909.00 864.00 1,314.00 1,830.00 1,587.00 843.00 817.00 923.00 823.00
EV/EBIT
15.75 16.65 15.69 15.22 10.40 9.55 14.53 13.70 14.76 12.78
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026